SlideShare a Scribd company logo
1 of 34
Anti-Inflammatory, Antiarthritis, 
and Related Agents 
Chapter 16 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Inflammatory Response 
• Protects the body from injury and pathogens 
• Used chemical mediators to produce a reaction that helps 
destroy pathogens and promotes healing 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Anti-Inflammatory, Antiarthritis, and 
Related Agents 
• Several different types of drugs 
• Corticosteroids 
• Block or alter the chemical reactions associated with the 
inflammatory response 
• Over-the-counter (OTC) 
• Adverse effects 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Salicylates 
• Can block the inflammatory response 
• Have antipyretic properties (fever-blocking) 
• Have analgesic (pain-blocking) properties 
• Therapeutic actions and indications 
• Pharmacokinetics 
• Contraindications and cautions 
• Adverse effects 
• Clinically important drug-to-drug interactions 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Common Salicylates 
• Aspirin (Bayer, etc.): Treats inflammatory conditions 
• Balsalazide (Colazal): New drug treats ulcerative colitis 
• Choline magnesium trisalicylate (Trilisate): Treats mild 
pain and fevers and arthritis 
• Choline Salicylate (Arthropan): Treats mild pain and fevers 
as well as arthritis 
• Mesalamine (Pentasa and others): Treats inflammation of 
the large intestine 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Common Salicylates (cont.) 
• Olsalazine (Dipentum): Converted to mesalamine in 
the colon; has the same direct anti-inflammatory effects 
• Salsalate (Argesic and Others): Used to treat pain, 
fever, and inflammation 
• Sodium Thiosalicylate (Rexolate): Treats episodes of 
acute gout and muscular pain, and rheumatic fever 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Salicylates 
• Actions /Indications 
– Inhibit synthesis of progtagladin, used to treat mild to 
moderate pain and fever 
• Pharmacokinetics 
– Absorbed from the stomach, peak in 5-30 min., 
metabolized in the liver, excreted in the urine 
• Contraindications 
– Known allergy, bleeding abnormalities, impaired renal 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
function 
• Drug-to-Drug Interactions 
– Interact with other drugs by interfering with absorption
Prototype Salicylates 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients 
Receiving Salicylates 
• Assessment: History and Examination 
• Nursing Diagnoses 
• Implementation With Rationale 
• Evaluation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Question 
Please answer the following statement as true or false. 
A person who does not respond to one salicylate may 
respond to a different one. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
True. 
Rationale: Salicylates are some of the oldest anti-inflammatory 
drugs used. They were extracted from 
willow bark, poplar trees, and other plants by ancient 
peoples to treat fever, pain, and what we now call 
inflammation. They are generally available without 
prescription and are relatively nontoxic when used as 
directed. A person who does not respond to one salicylate 
may respond to a different one. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nonsteroidal Anti-inflammatory and 
Related Agents 
• Propionic Acids 
– Fenoprofen 
– Ibuprofen 
• Acetic Acids 
– Declofenac 
– Etodolac 
• Fenamates 
– Mefenamic acid 
• Cyclooxygenase-2 
Inhibitors 
– Celecoxib 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
NSAIDs 
• Provide strong anti-inflammatory and analgesic effects 
• Sold over the counter, which may lead to abuse 
• Therapeutic actions and indications 
• Pharmacokinetics 
• Contraindications and cautions 
• Adverse effects 
• Clinically important drug-to-drug interactions 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype NSAIDs 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Acetaminophen 
• Actions /Indications 
– Acts directly on the thermoregulatory cells of the 
hypothalamus 
– Not sure of the mechanism of action related to analgesic 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins 
effects 
– Used to treat pain and fever 
• Treat pain and fever associated with a variety of 
conditions, including influenza 
• Prophylaxis of children receiving diphtheria–pertussis– 
tetanus (DPT) immunizations 
• Relief of musculoskeletal pain associated with arthritis
Acetaminophen (cont.) 
• Pharmacokinetics 
– Absorbed from GI tract 
– Peak ½ to 2 hours 
– Metabolized in the liver 
– Excreted in the urine 
– T ½ is about 2 hours 
• Contraindications 
– Known allergy 
– Use with caution in pregnancy and lactation 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Acetaminophen (cont.) 
• Adverse Reactions 
– Headache, hemolytic anemia, renal dysfunction, 
skin rash and fever 
– Hepatotoxicity usually associated with chronic 
use and overdose 
• Drug-to-Drug Interactions 
– Oral anticoagulants increase bleeding 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: Acetaminophen 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients 
Receiving NSAIDs and Related Agents 
• Assessment: History and Examination 
– Contraindications or cautions 
– Baseline status before beginning therapy and for any 
potential adverse effects 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Question 
When are NSAIDs contraindicated? 
A. Allergy to penicillin 
B. Allergy to sulfonamides 
C. Allergy to antihistamines 
D. Allergy to thiazines 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Answer 
B. Allergy to sulfonamides 
Rationale: The NSAIDs are contraindicated in the presence 
of allergy to any NSAID or salicylate/ Celecoxib is also 
contraindicated in the presence of allergy to 
sulfonamides. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antiarthritis Agents 
• Potentially debilitating inflammatory process 
• Antiarthritis drugs 
• Prevent and suppress arthritis in selected patients with 
rheumatoid arthritis 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Gold Compounds 
• Indications/Action 
– Absorbed by macrophages, which results in inhibition 
of phagocytosis 
– Tissue destruction is decreased 
• Pharmacokinetics 
– Absorptions varies based on site of administration 
– Widely distributed throughout the body 
• Contraindications 
– Known allergy 
– Diabetes, CHF, renal or hepatic impairment 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Gold Compounds (cont.) 
• Adverse Reactions 
– Stomatitis, glossitis, gingivitis, bone marrow 
depression, dermatitis 
• Drug-to-Drug Interactions 
– Penicillamine, antimalarials, cytotoxic drugs, or 
immunosuppressive agents 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Therapeutic Actions and Indications 
• Chrysotherapy 
• Indicated to treat selected cases of: 
– Rheumatoid arthritis 
– Juvenile rheumatoid arthritis 
– In patients whose disease has been unresponsive to 
standard therapy 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pharmacokinetics 
• Absorbed at varying rates 
• Excreted in urine and feces 
• Cross the placenta and cross into breast milk 
• Barrier contraceptives 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Contraindications and Cautions 
• Gold salts can be quite toxic 
• Contraindicated in the presence of any known allergy to 
gold 
Adverse Effects 
– Variety of adverse effects are common with the use 
of gold salts 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Clinically Important Drug–Drug 
Interactions 
• Do not combine with: 
– Penicillamine 
– Antimalarials 
– Cytotoxic drugs 
– Immunosuppressive agents 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Gold Compound 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Disease Modifying Anti-Rheumatic Drugs 
• Available for treating arthritis that aggressively affect the 
process of inflammation 
• Can be severe to life-threatening 
• They alter the course of the inflammatory process, many 
rheumatologists are selecting to 
• Antineoplastic drug methotrexate 
• Therapeutic Actions and Indications 
– Anakinra 
– Leflunomide is slowly absorbed from the GI tract, 
reaching peak levels in 6-12 hours 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Disease Modifying Anti-Rheumatic Drugs 
(cont.) 
• Anakinra 
• Etanercept I 
• Leflunomide is slowly absorbed from the GI tract, 
reaching peak levels in 6-12 hours. 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Therapeutic Actions and Indications 
• Relief of the signs and symptoms of rheumatoid arthritis 
and osteoarthritis 
• Relief of mild to moderate pain 
• Treatment of primary dysmenorrhea 
• Fever reduction 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients 
Receiving Antiarthritis Agents 
• Similar to those for patients receiving NSAIDS and 
related agents 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Drug Therapy Across the Lifespan 
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins

More Related Content

What's hot

Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40stanbridge
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48stanbridge
 
Ppt chapter 39
Ppt chapter 39Ppt chapter 39
Ppt chapter 39stanbridge
 
Ppt chapter 01
Ppt chapter 01Ppt chapter 01
Ppt chapter 01stanbridge
 
Ppt chapter 02
Ppt chapter 02Ppt chapter 02
Ppt chapter 02stanbridge
 
Ppt chapter 39
Ppt chapter 39Ppt chapter 39
Ppt chapter 39stanbridge
 
Ppt chapter 34
Ppt chapter 34Ppt chapter 34
Ppt chapter 34stanbridge
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59stanbridge
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1stanbridge
 
Levoflox (Levofloxacin Tablets)
Levoflox (Levofloxacin Tablets)Levoflox (Levofloxacin Tablets)
Levoflox (Levofloxacin Tablets)Clearsky Pharmacy
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16stanbridge
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35stanbridge
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41stanbridge
 
ADDED 2 NCP.docx
ADDED 2 NCP.docxADDED 2 NCP.docx
ADDED 2 NCP.docxNasaAranda
 
Exposing the myth of vaccination essential information you need to know to be...
Exposing the myth of vaccination essential information you need to know to be...Exposing the myth of vaccination essential information you need to know to be...
Exposing the myth of vaccination essential information you need to know to be...db61
 
FLORENCE NIGHTINGALE: ENVIRONMENTAL THEORY
FLORENCE NIGHTINGALE: ENVIRONMENTAL THEORYFLORENCE NIGHTINGALE: ENVIRONMENTAL THEORY
FLORENCE NIGHTINGALE: ENVIRONMENTAL THEORYRommel Luis III Israel
 
Ppt chapter 37-1
Ppt chapter 37-1Ppt chapter 37-1
Ppt chapter 37-1stanbridge
 
Pharmacology powerpoint git drugs
Pharmacology powerpoint  git drugsPharmacology powerpoint  git drugs
Pharmacology powerpoint git drugsFred Ecaldre
 

What's hot (20)

Ppt chapter 40
Ppt chapter 40Ppt chapter 40
Ppt chapter 40
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48
 
Ppt chapter 39
Ppt chapter 39Ppt chapter 39
Ppt chapter 39
 
Ppt chapter 01
Ppt chapter 01Ppt chapter 01
Ppt chapter 01
 
Ppt chapter 02
Ppt chapter 02Ppt chapter 02
Ppt chapter 02
 
Ppt chapter 39
Ppt chapter 39Ppt chapter 39
Ppt chapter 39
 
Ppt chapter 34
Ppt chapter 34Ppt chapter 34
Ppt chapter 34
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1
 
Levoflox (Levofloxacin Tablets)
Levoflox (Levofloxacin Tablets)Levoflox (Levofloxacin Tablets)
Levoflox (Levofloxacin Tablets)
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35
 
Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41
 
Chapter 06
Chapter 06Chapter 06
Chapter 06
 
ADDED 2 NCP.docx
ADDED 2 NCP.docxADDED 2 NCP.docx
ADDED 2 NCP.docx
 
Exposing the myth of vaccination essential information you need to know to be...
Exposing the myth of vaccination essential information you need to know to be...Exposing the myth of vaccination essential information you need to know to be...
Exposing the myth of vaccination essential information you need to know to be...
 
FLORENCE NIGHTINGALE: ENVIRONMENTAL THEORY
FLORENCE NIGHTINGALE: ENVIRONMENTAL THEORYFLORENCE NIGHTINGALE: ENVIRONMENTAL THEORY
FLORENCE NIGHTINGALE: ENVIRONMENTAL THEORY
 
Ppt chapter 37-1
Ppt chapter 37-1Ppt chapter 37-1
Ppt chapter 37-1
 
Pharmacology powerpoint git drugs
Pharmacology powerpoint  git drugsPharmacology powerpoint  git drugs
Pharmacology powerpoint git drugs
 
Lydia hall (core, care & cure) nursing theory
Lydia hall (core, care & cure) nursing theoryLydia hall (core, care & cure) nursing theory
Lydia hall (core, care & cure) nursing theory
 

Viewers also liked

Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20stanbridge
 
Ppt chapter 29
Ppt chapter 29Ppt chapter 29
Ppt chapter 29stanbridge
 
Drugs affecting respiratory system
Drugs affecting respiratory systemDrugs affecting respiratory system
Drugs affecting respiratory systemAsare Sylvester
 
Nursing case study Pre eclampsia
Nursing case study Pre eclampsiaNursing case study Pre eclampsia
Nursing case study Pre eclampsiapinoy nurze
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISshruti87
 
Pharmacology Respiratory Drugs
Pharmacology   Respiratory DrugsPharmacology   Respiratory Drugs
Pharmacology Respiratory Drugspinoy nurze
 

Viewers also liked (8)

Chapter020
Chapter020Chapter020
Chapter020
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20
 
DMARDs
DMARDsDMARDs
DMARDs
 
Ppt chapter 29
Ppt chapter 29Ppt chapter 29
Ppt chapter 29
 
Drugs affecting respiratory system
Drugs affecting respiratory systemDrugs affecting respiratory system
Drugs affecting respiratory system
 
Nursing case study Pre eclampsia
Nursing case study Pre eclampsiaNursing case study Pre eclampsia
Nursing case study Pre eclampsia
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITIS
 
Pharmacology Respiratory Drugs
Pharmacology   Respiratory DrugsPharmacology   Respiratory Drugs
Pharmacology Respiratory Drugs
 

Similar to Ppt chapter 16-1

Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36stanbridge
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59stanbridge
 
Ppt chapter 26-1
Ppt chapter 26-1Ppt chapter 26-1
Ppt chapter 26-1stanbridge
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52stanbridge
 
Ppt chapter 52-1
Ppt chapter 52-1Ppt chapter 52-1
Ppt chapter 52-1stanbridge
 
Ppt chapter 30-1
Ppt chapter 30-1Ppt chapter 30-1
Ppt chapter 30-1stanbridge
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48stanbridge
 
Ppt chapter 33
Ppt chapter 33Ppt chapter 33
Ppt chapter 33stanbridge
 
Ppt chapter 24-1
Ppt chapter 24-1Ppt chapter 24-1
Ppt chapter 24-1stanbridge
 
Ppt chapter 24
Ppt chapter 24Ppt chapter 24
Ppt chapter 24stanbridge
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1stanbridge
 
Ppt chapter 38-1
Ppt chapter 38-1Ppt chapter 38-1
Ppt chapter 38-1stanbridge
 
Ppt chapter 18
Ppt chapter 18Ppt chapter 18
Ppt chapter 18stanbridge
 
Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38stanbridge
 
Ppt chapter 32-1
Ppt chapter 32-1Ppt chapter 32-1
Ppt chapter 32-1stanbridge
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48stanbridge
 
Ppt chapter 42
Ppt chapter 42Ppt chapter 42
Ppt chapter 42stanbridge
 

Similar to Ppt chapter 16-1 (20)

Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36
 
Ppt chapter 59
Ppt chapter 59Ppt chapter 59
Ppt chapter 59
 
Ppt chapter 26-1
Ppt chapter 26-1Ppt chapter 26-1
Ppt chapter 26-1
 
Ppt chapter 52
Ppt chapter 52Ppt chapter 52
Ppt chapter 52
 
Ppt chapter 52-1
Ppt chapter 52-1Ppt chapter 52-1
Ppt chapter 52-1
 
Ppt chapter 30-1
Ppt chapter 30-1Ppt chapter 30-1
Ppt chapter 30-1
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48
 
Ppt chapter 33
Ppt chapter 33Ppt chapter 33
Ppt chapter 33
 
Ppt chapter 24-1
Ppt chapter 24-1Ppt chapter 24-1
Ppt chapter 24-1
 
Ppt chapter 24
Ppt chapter 24Ppt chapter 24
Ppt chapter 24
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 35-1
Ppt chapter 35-1Ppt chapter 35-1
Ppt chapter 35-1
 
Ppt chapter 38-1
Ppt chapter 38-1Ppt chapter 38-1
Ppt chapter 38-1
 
Ppt chapter 18
Ppt chapter 18Ppt chapter 18
Ppt chapter 18
 
Ppt chapter 38
Ppt chapter 38Ppt chapter 38
Ppt chapter 38
 
Ppt chapter 32-1
Ppt chapter 32-1Ppt chapter 32-1
Ppt chapter 32-1
 
Ppt chapter 48
Ppt chapter 48Ppt chapter 48
Ppt chapter 48
 
Ppt chapter 42
Ppt chapter 42Ppt chapter 42
Ppt chapter 42
 

More from stanbridge

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecturestanbridge
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2stanbridge
 
Creating a poster
Creating a posterCreating a poster
Creating a posterstanbridge
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Disseminationstanbridge
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5stanbridge
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4stanbridge
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors stanbridge
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learnerstanbridge
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policystanbridge
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentstanbridge
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005stanbridge
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007stanbridge
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006stanbridge
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004stanbridge
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009stanbridge
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008stanbridge
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21stanbridge
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22stanbridge
 

More from stanbridge (20)

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecture
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2
 
Creating a poster
Creating a posterCreating a poster
Creating a poster
 
Sample poster
Sample posterSample poster
Sample poster
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Dissemination
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learner
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policy
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessment
 
Ot5101 week1
Ot5101 week1Ot5101 week1
Ot5101 week1
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22
 

Ppt chapter 16-1

  • 1. Anti-Inflammatory, Antiarthritis, and Related Agents Chapter 16 Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 2. Inflammatory Response • Protects the body from injury and pathogens • Used chemical mediators to produce a reaction that helps destroy pathogens and promotes healing Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 3. Anti-Inflammatory, Antiarthritis, and Related Agents • Several different types of drugs • Corticosteroids • Block or alter the chemical reactions associated with the inflammatory response • Over-the-counter (OTC) • Adverse effects Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 4. Salicylates • Can block the inflammatory response • Have antipyretic properties (fever-blocking) • Have analgesic (pain-blocking) properties • Therapeutic actions and indications • Pharmacokinetics • Contraindications and cautions • Adverse effects • Clinically important drug-to-drug interactions Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 5. Common Salicylates • Aspirin (Bayer, etc.): Treats inflammatory conditions • Balsalazide (Colazal): New drug treats ulcerative colitis • Choline magnesium trisalicylate (Trilisate): Treats mild pain and fevers and arthritis • Choline Salicylate (Arthropan): Treats mild pain and fevers as well as arthritis • Mesalamine (Pentasa and others): Treats inflammation of the large intestine Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 6. Common Salicylates (cont.) • Olsalazine (Dipentum): Converted to mesalamine in the colon; has the same direct anti-inflammatory effects • Salsalate (Argesic and Others): Used to treat pain, fever, and inflammation • Sodium Thiosalicylate (Rexolate): Treats episodes of acute gout and muscular pain, and rheumatic fever Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 7. Salicylates • Actions /Indications – Inhibit synthesis of progtagladin, used to treat mild to moderate pain and fever • Pharmacokinetics – Absorbed from the stomach, peak in 5-30 min., metabolized in the liver, excreted in the urine • Contraindications – Known allergy, bleeding abnormalities, impaired renal Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins function • Drug-to-Drug Interactions – Interact with other drugs by interfering with absorption
  • 8. Prototype Salicylates Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 9. Nursing Considerations for Patients Receiving Salicylates • Assessment: History and Examination • Nursing Diagnoses • Implementation With Rationale • Evaluation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 10. Question Please answer the following statement as true or false. A person who does not respond to one salicylate may respond to a different one. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 11. Answer True. Rationale: Salicylates are some of the oldest anti-inflammatory drugs used. They were extracted from willow bark, poplar trees, and other plants by ancient peoples to treat fever, pain, and what we now call inflammation. They are generally available without prescription and are relatively nontoxic when used as directed. A person who does not respond to one salicylate may respond to a different one. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 12. Nonsteroidal Anti-inflammatory and Related Agents • Propionic Acids – Fenoprofen – Ibuprofen • Acetic Acids – Declofenac – Etodolac • Fenamates – Mefenamic acid • Cyclooxygenase-2 Inhibitors – Celecoxib Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 13. NSAIDs • Provide strong anti-inflammatory and analgesic effects • Sold over the counter, which may lead to abuse • Therapeutic actions and indications • Pharmacokinetics • Contraindications and cautions • Adverse effects • Clinically important drug-to-drug interactions Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 14. Prototype NSAIDs Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 15. Acetaminophen • Actions /Indications – Acts directly on the thermoregulatory cells of the hypothalamus – Not sure of the mechanism of action related to analgesic Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins effects – Used to treat pain and fever • Treat pain and fever associated with a variety of conditions, including influenza • Prophylaxis of children receiving diphtheria–pertussis– tetanus (DPT) immunizations • Relief of musculoskeletal pain associated with arthritis
  • 16. Acetaminophen (cont.) • Pharmacokinetics – Absorbed from GI tract – Peak ½ to 2 hours – Metabolized in the liver – Excreted in the urine – T ½ is about 2 hours • Contraindications – Known allergy – Use with caution in pregnancy and lactation Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 17. Acetaminophen (cont.) • Adverse Reactions – Headache, hemolytic anemia, renal dysfunction, skin rash and fever – Hepatotoxicity usually associated with chronic use and overdose • Drug-to-Drug Interactions – Oral anticoagulants increase bleeding Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 18. Prototype Summary: Acetaminophen Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 19. Nursing Considerations for Patients Receiving NSAIDs and Related Agents • Assessment: History and Examination – Contraindications or cautions – Baseline status before beginning therapy and for any potential adverse effects Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 20. Question When are NSAIDs contraindicated? A. Allergy to penicillin B. Allergy to sulfonamides C. Allergy to antihistamines D. Allergy to thiazines Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 21. Answer B. Allergy to sulfonamides Rationale: The NSAIDs are contraindicated in the presence of allergy to any NSAID or salicylate/ Celecoxib is also contraindicated in the presence of allergy to sulfonamides. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 22. Antiarthritis Agents • Potentially debilitating inflammatory process • Antiarthritis drugs • Prevent and suppress arthritis in selected patients with rheumatoid arthritis Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 23. Gold Compounds • Indications/Action – Absorbed by macrophages, which results in inhibition of phagocytosis – Tissue destruction is decreased • Pharmacokinetics – Absorptions varies based on site of administration – Widely distributed throughout the body • Contraindications – Known allergy – Diabetes, CHF, renal or hepatic impairment Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 24. Gold Compounds (cont.) • Adverse Reactions – Stomatitis, glossitis, gingivitis, bone marrow depression, dermatitis • Drug-to-Drug Interactions – Penicillamine, antimalarials, cytotoxic drugs, or immunosuppressive agents Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 25. Therapeutic Actions and Indications • Chrysotherapy • Indicated to treat selected cases of: – Rheumatoid arthritis – Juvenile rheumatoid arthritis – In patients whose disease has been unresponsive to standard therapy Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 26. Pharmacokinetics • Absorbed at varying rates • Excreted in urine and feces • Cross the placenta and cross into breast milk • Barrier contraceptives Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 27. Contraindications and Cautions • Gold salts can be quite toxic • Contraindicated in the presence of any known allergy to gold Adverse Effects – Variety of adverse effects are common with the use of gold salts Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 28. Clinically Important Drug–Drug Interactions • Do not combine with: – Penicillamine – Antimalarials – Cytotoxic drugs – Immunosuppressive agents Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 29. Prototype Gold Compound Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 30. Disease Modifying Anti-Rheumatic Drugs • Available for treating arthritis that aggressively affect the process of inflammation • Can be severe to life-threatening • They alter the course of the inflammatory process, many rheumatologists are selecting to • Antineoplastic drug methotrexate • Therapeutic Actions and Indications – Anakinra – Leflunomide is slowly absorbed from the GI tract, reaching peak levels in 6-12 hours Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 31. Disease Modifying Anti-Rheumatic Drugs (cont.) • Anakinra • Etanercept I • Leflunomide is slowly absorbed from the GI tract, reaching peak levels in 6-12 hours. Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 32. Therapeutic Actions and Indications • Relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis • Relief of mild to moderate pain • Treatment of primary dysmenorrhea • Fever reduction Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 33. Nursing Considerations for Patients Receiving Antiarthritis Agents • Similar to those for patients receiving NSAIDS and related agents Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 34. Drug Therapy Across the Lifespan Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins